JD HEALTH 06618Hong Kong Stock Exchange

36.0802.04%( +0.720 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
JD HEALTH (06618) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2020-12-08
Industry
Pharmaceutical Distribution
Fiscal Year End
Dec 31
ISIN
KYG5074A1004
Southbound Connect
Shanghai · Shenzhen

Related Securities

Industry

Pharmaceutical Distribution 0.24%
20 stocks in this industry
Down 5 Up 11
Industry RankingsValue (HKD)Rank
Revenue (Last FY)86.12B3/19
Net Profit (Last FY)6.30B2/19
ROE (Last FY)8.95%4/19

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Dong Cao Executive Director
Richard Qiangdong Liu Non-Executive Director
Xingyao Chen Independent Non-Executive Director
Ling Li Independent Non-Executive Director
Jiyu Zhang Independent Non-Executive Director
Ying Wu Independent Non-Executive Director
George Lau Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-09-30.

About this page

This page shows JD HEALTH (06618) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.